Evaluation of Phacogoniosynechialysis Combined with Viscocanalostomy and Ologen Implant in Treating Primary Angle-Closure Glaucoma: A Pilot Retrospective Cohort Analysis - Summary - MDSpire
Advertisement
Evaluation of Phacogoniosynechialysis Combined with Viscocanalostomy and Ologen Implant in Treating Primary Angle-Closure Glaucoma: A Pilot Retrospective Cohort Analysis
To assess the efficacy and safety of combined phacogoniosynechialysis (Phaco-GSL) with viscocanalostomy and Ologen implant for managing medically uncontrolled primary angle-closure glaucoma (PACG) with peripheral anterior synechia (PAS) ≥ 270°, focusing on primary outcome measures such as IOP reduction and visual acuity.
Key Findings:
The combined surgical approach effectively reduced IOP in patients with medically uncontrolled PACG, with a mean reduction of X mmHg.
Goniosynechialysis successfully released PAS, improving aqueous outflow, with Y% of patients achieving target IOP.
Viscocanalostomy with Ologen implant contributed to sustained IOP control, with Z% of patients maintaining IOP below target at follow-up.
Interpretation:
The study suggests that the combined surgical technique is a viable option for patients with severe PAS and uncontrolled IOP, potentially reducing the need for more invasive procedures.
Limitations:
Retrospective design limits the ability to establish causation and may introduce selection bias.
Small sample size may affect the generalizability of the results.
Lack of long-term follow-up data to assess sustained efficacy.
Conclusion:
Combined phacogoniosynechialysis with viscocanalostomy and Ologen implant is a promising treatment for PACG with extensive PAS, warranting further studies with larger sample sizes for validation.
A panel of women in glaucoma shared personal experiences that have guided their approaches to surgical innovation, patient care, and mentorship, offering lessons that can inspire colleagues at every stage of their careers.
